Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Direxion Daily LLY Bull 2X Shares (ELIL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: ELIL (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -3.49% | Avg. Invested days 9 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 15.91 - 26.62 | Updated Date 04/5/2025 |
52 Weeks Range 15.91 - 26.62 | Updated Date 04/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Direxion Daily LLY Bull 2X Shares
Company Overview
History and Background
The Direxion Daily LLY Bull 2X Shares (ULLY) is an exchange-traded fund (ETF) that seeks daily investment results, before fees and expenses, of 200% of the performance of the common stock of Eli Lilly and Company (LLY). It was likely launched by Direxion Funds to provide leveraged exposure to LLY's stock.
Core Business Areas
- Leveraged ETF: ULLY provides leveraged exposure to Eli Lilly and Company (LLY), aiming for twice the daily performance. This is a single business segment.
Leadership and Structure
Direxion Funds manages ULLY. Specific leadership details for the fund are generally available on Direxion's website. Direxion is a registered investment advisor and sponsor of exchange traded funds.
Top Products and Market Share
Key Offerings
- Direxion Daily LLY Bull 2X Shares (ULLY): This leveraged ETF aims to deliver twice the daily performance of Eli Lilly and Company (LLY). Market share data for specific leveraged ETFs can fluctuate significantly and is best obtained from current fund flow reports. Competitors include other leveraged ETFs focusing on the pharmaceutical or healthcare sectors, although direct competitors mirroring LLY exposure are limited.
Market Dynamics
Industry Overview
The ETF market is highly competitive, with numerous providers offering a wide range of investment strategies. Leveraged ETFs offer the potential for amplified returns but also carry increased risk.
Positioning
ULLY is positioned as a tool for investors seeking short-term, leveraged exposure to Eli Lilly's stock. It is not intended for long-term investment due to the effects of compounding and daily resets.
Total Addressable Market (TAM)
The TAM for leveraged ETFs is significant, encompassing investors seeking short-term gains across various sectors. ULLY captures a portion of this TAM related specifically to leveraged exposure to Eli Lilly.
Upturn SWOT Analysis
Strengths
- Leveraged Exposure
- Liquidity
- Transparency (Daily Holdings)
- Relatively Low Expense Ratio compared to some other leveraged ETFs
Weaknesses
- Compounding Effect
- High Volatility
- Not Suitable for Long-Term Investment
- Potential for Significant Losses
Opportunities
- Increased Investor Interest in Leveraged Products
- Growth in Pharmaceutical Sector
- Innovation in ETF Structures
- Strategic Partnerships
Threats
- Regulatory Changes
- Market Downturn
- Competition from Similar Products
- Changes in Eli Lilly's Performance
Competitors and Market Share
Key Competitors
- LABU
- TECL
- Other Leveraged ETFs
Competitive Landscape
ULLY's competitive advantage lies in its specific focus on providing leveraged exposure to Eli Lilly. The primary disadvantage is the inherent risk associated with leveraged ETFs.
Growth Trajectory and Initiatives
Historical Growth: ULLY's growth is directly tied to the price appreciation of LLY.
Future Projections: Future performance is highly dependent on LLY's performance and overall market conditions. Analyst estimates regarding future growth are tied to expectations for the pharmaceutical sector and Eli Lilly specifically.
Recent Initiatives: Recent initiatives would relate to Direxion's overall ETF strategy and marketing efforts.
Summary
ULLY is a leveraged ETF designed for short-term trading strategies focused on Eli Lilly's stock performance. Its performance is directly linked to LLY, amplified by 2x leverage, presenting both opportunities for gains and significant risks of losses. Investors should be aware of the compounding effect and daily reset, making it unsuitable for long-term holding. Potential threats include market downturns and regulatory changes affecting leveraged products. The fund offers liquidity and transparency but requires active monitoring and a strong understanding of leveraged investments.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Direxion Funds Website
- Yahoo Finance
- Bloomberg
- ETF.com
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Leveraged ETFs are complex financial instruments and carry significant risks. Investors should consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Direxion Daily LLY Bull 2X Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2025-03-26 | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The fund, under normal circumstances, invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of LLY and financial instruments, such as swap agreements and options, that, in combination, provide 2X daily leveraged exposure to LLY, consistent with the fund"s investment objective. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.